Company profile for Derm-Biome Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Derm-Biome Pharmaceuticals, Inc. is a startup biopharmaceutical company founded in 2018 through its purchase of proprietary birch bark natural compound derivatives. Almost $6M dollars has been invested into advancing our suite of compounds, resulting in promising results showing that they have potent anti-inflammatory effects in diseases such as atopic dermatitis, they have anti-microbial activity to potentially balance the sk...
Derm-Biome Pharmaceuticals, Inc. is a startup biopharmaceutical company founded in 2018 through its purchase of proprietary birch bark natural compound derivatives. Almost $6M dollars has been invested into advancing our suite of compounds, resulting in promising results showing that they have potent anti-inflammatory effects in diseases such as atopic dermatitis, they have anti-microbial activity to potentially balance the skin microbiome, they improve skin appearance (potentially through enhanced skin turnover), and they are highly selective for killing tumor cells versus normal cells derived from patients with skin cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
1310 Richards Street 2704 Vancouver, BC V6B3G6, CA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/25/2986824/0/en/Derm-Biome-Pharmaceuticals-adds-Dr-Jerry-Tan-internationally-renowned-expert-in-acne-and-acne-scarring-to-its-Scientific-Advisory-Board.html

GLOBENEWSWIRE
25 Nov 2024

https://www.globenewswire.com/news-release/2024/08/13/2929332/0/en/Derm-Biome-Pharmaceuticals-to-develop-skincare-treatment-that-promotes-skin-health-and-longevity.html

GLOBENEWSWIRE
13 Aug 2024

https://www.globenewswire.com/news-release/2024/05/08/2877949/0/en/Derm-Biome-Pharmaceuticals-and-TransBIOtech-awarded-450-000-Applied-Research-and-Development-ARD-grant-funding.html

GLOBENEWSWIRE
08 May 2024

https://www.globenewswire.com/news-release/2024/04/17/2864703/0/en/Derm-Biome-Pharmaceuticals-topical-therapy-shows-positive-results-in-preclinical-skin-cancer-trial-drug-prevents-the-development-of-precancerous-skin-conditions-and-treats-existing.html

GLOBENEWSWIRE
17 Apr 2024

https://www.globenewswire.com//news-release/2024/02/27/2836165/0/en/Derm-Biome-Pharmaceuticals-prepares-to-begin-IND-enabling-studies-for-DB-007-4-a-potential-best-in-class-treatment-for-inflammatory-skin-diseases.html

GLOBENEWSWIRE
27 Feb 2024

https://www.globenewswire.com//news-release/2023/11/28/2787128/0/en/Derm-Biome-Pharmaceuticals-Announces-Collaboration-with-Massachusetts-General-Hospital-in-Skin-Cancer-Study.html

GLOBENEWSWIRE
28 Nov 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty